Results 131 to 140 of about 35,769 (259)

Identification of Crucial Drug Targets and Pathways to Reprogram Drug Resistance Through Epigenetic Modulation in Advanced Lung Cancer Using Integrated Bioinformatics Approach

open access: yesComputational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Resistance to chemotherapy, which is demonstrated in almost every patient with advanced‐stage lung cancer (ALC), underscores an urgent need to unravel the underlying molecular mechanisms and identify novel strategies to overcome drug resistance. In the present study, an attempt was made to identify epigenetic targets and modulators that can be
Okibur Rahman   +2 more
wiley   +1 more source

Effects of FGF2 and antagonist of FGF2 receptor-1 on the excitability of dopamine neurons in rats

open access: yesNeuroscience Applied, 2022
E. Dremencov   +5 more
openaire   +1 more source

Nucleolin binds to FGF1 and FGF2.

open access: yes, 2014
A) Proteins from cleared cell lysates (BJ or NIH3T3 cells) were pulled down by SBP-FGF1, Biot-FGF2, His-FGF1, GST-FGF1, GST-FGF2, GST protein, or no protein (–), and respective resins (Streptavidin-coated Dynabeads, Ni-NTA Superflow or Glutathione ...
Torunn Sletten (530507)   +9 more
core   +1 more source

Engineering Extracellular Vesicles for Anti‐Aging Therapy: Mechanisms, Applications, and Perspectives

open access: yesAging Cell, Volume 25, Issue 7, July 2026.
This review systematically elucidates the multifactorial anti‐aging mechanisms of extracellular vesicles (EVs). By bridging fundamental biology with advanced bioengineering, scalable manufacturing, and clinical translation, it establishes a comprehensive framework for developing next‐generation EVs‐based precision nanotherapeutics to combat systemic ...
Xian Huang   +6 more
wiley   +1 more source

Fibroblast growth factor 2 promotes osteo/odontogenic differentiation in stem cells from the apical papilla by inhibiting PI3K/AKT pathway

open access: yesScientific Reports
Fibroblast growth factor 2 (FGF2) is a crucial factor in odontoblast differentiation and dentin matrix deposition, which facilitates pulpodentin repair and regeneration.
Zijie Wang   +6 more
doaj   +1 more source

SIK2: A Novel Negative Feedback Regulator of FGF2 Signaling

open access: yesAdvanced Biology
Abstract A wide range of cells respond to fibroblast growth factor 2 (FGF2) by proliferation via activation of the Ras/ERK1/2 pathway. In this study, the potential involvement of salt inducible kinase SIK2) in this cascade within retinal Müller glia is explored.
Gamze Kuser‐Abali   +5 more
openaire   +3 more sources

α-Tocopheryl succinate inhibits angiogenesis by disrupting paracrine FGF2 signalling

open access: yes, 2007
Malignant mesothelioma (MM) cells enhanced proliferation of endothelial cells (ECs) as well as their angiogenesis in vitro by secretion of fibroblast growth factor-2 (FGF2). This effect was suppressed by pre-treating MM cells with α-tocopheryl succinate (
Stapelberg, Michael   +11 more
core   +1 more source

Genomic Analysis of Inbreeding Depression on Productive Traits in Rubia Galega Beef Cattle Breed

open access: yesJournal of Animal Breeding and Genetics, Volume 143, Issue 4, Page 508-523, July 2026.
ABSTRACT In autochthonous livestock breeds with small populations, such as the Rubia Galega from Galicia (Spain), mating between relatives is common and can lead to inbreeding depression. Genomic inbreeding coefficients were estimated for 4984 animals using ~63,000 SNPs to assess inbreeding depression in four key traits: age at first calving (AFC) with
N. Mejuto‐Vázquez   +6 more
wiley   +1 more source

FGF2 treatment increases the absolute number of tectal cells.

open access: yes, 2013
Intra-ventricular injections of FGF2 on ED4 decrease the number of cells above a unit area of ventricular surface by 14% compared to controls (A). Taking into account our previous observation that FGF2 increases tectal ventricular surface area by 181% [3]
Luke D. McGowan (483282)   +2 more
core   +1 more source

Small Extracellular Vesicles from Neural Cells: Physiological and Pathological Roles, and Potential in Neurodegenerative Therapy

open access: yesAdvanced Healthcare Materials, Volume 15, Issue 21, 5 June 2026.
Neural cell–derived small extracellular vesicles (sEVs) are emerging as pivotal mediators in neurodegenerative diseases, exerting both pathogenic and therapeutic functions. This review synthesizes current evidence on how sEVs from distinct neural cell types regulate neurodegeneration, neuroprotection, biomarker discovery, and targeted drug delivery ...
Muhammad Waqas Salim   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy